Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
26.06. | VITA LIFE SCIENCES LIMITED: Notification of cessation of securities - VLS | - | ASX | ||
24.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
23.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
22.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
VITA LIFE SCIENCES Aktie jetzt für 0€ handeln | |||||
18.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
17.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
GREEN THUMB INDUSTRIES | 4,718 | +3,37 % | Green Thumb Industries Inc: Green Thumb to release Q2 2025 financial results Aug. 6 | ||
INDIVA | 0,016 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.06.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 20.06.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.06.2025.ISIN NameCA45580J1012 INDIVA... ► Artikel lesen | |
ALNYLAM PHARMACEUTICALS | 276,50 | -0,25 % | Alnylam Pharma Stock Outlook: Is ALNY Topping Out? | ||
CASSAVA SCIENCES | 1,750 | +3,00 % | Cassava Sciences reports simufilam reduced seizures in mouse model | ||
NEKTAR THERAPEUTICS | 19,500 | -3,70 % | Nektar Therapeutics Prices $100 Mln Public Offering Of Common Stock At $23.50 Per Share | WASHINGTON (dpa-AFX) - Nektar Therapeutics (NKTR), a clinical-stage biotech firm specializing in immunotherapy, has priced its underwritten public offering of approximately $100 million in common... ► Artikel lesen | |
ADASTRA | 0,114 | 0,00 % | Adastra Holdings Ltd.: Adastra Holdings Announces New Director | Langley, British Columbia--(Newsfile Corp. - March 3, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian... ► Artikel lesen | |
SELLAS LIFE SCIENCES | 1,940 | +5,66 % | SELLAS Life Sciences Group, Inc.: SELLAS Presents Preclinical Efficacy of SLS009 in ASXL1 Mutated Colorectal Cancer at 2025 ASCO Annual Meeting | - ASCO Presentation Supports SLS009 as a Potential Targeted Therapy for ASXL1 Mutated Colorectal Cancer - - 22,500 New Cases of Colorectal Cancer with High Microsatellite Instability per Year in... ► Artikel lesen | |
ACADIA PHARMACEUTICALS | 17,570 | -0,62 % | Acadia CEO sets sights on 'much more assertive' deals to invigorate pipeline | ||
CATALYST PHARMACEUTICALS | 18,605 | +2,73 % | Catalyst Pharma: Viel Wachstum für wenig Geld? | Die meisten Biotech-Aktien sind vor allem eins: hochspekulativ. Catalyst Pharma beweist jedoch, dass es auch anders geht - mit realen Gewinnen und nachhaltigem Wachstum Den vollständigen Artikel lesen... ► Artikel lesen | |
MOLECULE HOLDINGS | 0,001 | 0,00 % | Molecule Holdings Inc: Molecule Holdings amends, converts 8% debentures | ||
NUMINUS WELLNESS | 0,027 | -100,00 % | XFRA LR23: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNUMINUS WELLNESS... ► Artikel lesen | |
ZELIRA THERAPEUTICS | 0,216 | -0,92 % | Zelira Therapeutics receives $1.15m R&D tax refund to support clinical programs | ||
OPUS GENETICS | 0,851 | +1,67 % | Opus Genetics, Inc.: Opus Genetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | RESEARCH TRIANGLE PARK, N.C., July 03, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited... ► Artikel lesen | |
SOLIGENIX | 1,240 | +3,33 % | Soligenix completes US manufacturing transfer for synthetic hypericin |